Real world study finds no evidence of increased cancer risk with JAKi vs TNFi in PsAMarch 23, 2023Psoriatic Arthritis
Guselkumab resolves dactylitis and improves clinical outcomes in patients with active PsAMarch 23, 2023Psoriatic Arthritis
Active disease in third trimester increases risk for emergency caesarean section in PsAMarch 23, 2023Psoriatic Arthritis
Achievement of low disease activity improves long-term structural damage in PsAMarch 23, 2023Psoriatic Arthritis
Gender-based differences in treatment outcomes and persistence with ustekinumab or TNFi in PsAMarch 23, 2023Psoriatic Arthritis
Rheumatology NewsPsoriatic arthritis treatment for women falls short, study suggestsMarch 23, 2023Psoriatic Arthritis
Rheumatology NewsBiologics show signs of delaying arthritis in psoriasis patientsMarch 9, 2023Psoriatic Arthritis
Rheumatology NewsIsolated nail psoriasis may bring arthritis into playFebruary 28, 2023Psoriatic Arthritis
Rheumatology NewsTreating nail psoriasis: Intralesional injections and biologicsFebruary 23, 2023Psoriatic Arthritis
Rheumatology NewsWhat’s holding back physicians from prescribing biosimilars? Four specialties weigh inFebruary 23, 2023Business of MedicineAnkylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesPediatrics
Rheumatology NewsExpert offers caveats to perioperative antirheumatic drug guidelineFebruary 23, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisOrthopedics
Rheumatology NewsNew influx of Humira biosimilars may not drive immediate changeFebruary 22, 2023Rheumatoid ArthritisPsoriatic ArthritisBusiness of MedicineSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsWhat does the future of psoriasis treatment look like?February 21, 2023Psoriatic Arthritis
